{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:33:54Z","timestamp":1785375234694,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Czech Health Research Council","doi-asserted-by":"publisher","award":["16-31689A"],"award-info":[{"award-number":["16-31689A"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project for Conceptual Development of Research Organization from the Ministry of Health of the Czech Republic.","award":["00023736"],"award-info":[{"award-number":["00023736"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Deferasirox (DFX) is an oral iron chelator used to reduce iron overload (IO) caused by frequent blood cell transfusions in anemic myelodysplastic syndrome (MDS) patients. To study the molecular mechanisms by which DFX improves outcome in MDS, we analyzed the global gene expression in untreated MDS patients and those who were given DFX treatment. The gene expression profiles of bone marrow CD34+ cells were assessed by whole-genome microarrays. Initially, differentially expressed genes (DEGs) were determined between patients with normal ferritin levels and those with IO to address the effect of excessive iron on cellular pathways. These DEGs were annotated to Gene Ontology terms associated with cell cycle, apoptosis, adaptive immune response and protein folding and were enriched in cancer-related pathways. The deregulation of multiple cancer pathways in iron-overloaded patients suggests that IO is a cofactor favoring the progression of MDS. The DEGs between patients with IO and those treated with DFX were involved predominantly in biological processes related to the immune response and inflammation. These data indicate DFX modulates the immune response mainly via neutrophil-related genes. Suppression of negative regulators of blood cell differentiation essential for cell maturation and upregulation of heme metabolism observed in DFX-treated patients may contribute to the hematopoietic improvement.<\/jats:p>","DOI":"10.3390\/ph14010041","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T01:51:58Z","timestamp":1609984318000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients"],"prefix":"10.3390","volume":"14","author":[{"given":"Hana","family":"Votavova","sequence":"first","affiliation":[{"name":"Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Urbanova","sequence":"additional","affiliation":[{"name":"First Faculty of Medicine, Charles University, Katerinsk\u00e1 32, 121 08 Prague, Czech Republic"},{"name":"Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kundrat","sequence":"additional","affiliation":[{"name":"Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6345-9180","authenticated-orcid":false,"given":"Michaela","family":"Dostalova Merkerova","sequence":"additional","affiliation":[{"name":"Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vostry","sequence":"additional","affiliation":[{"name":"Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hruba","sequence":"additional","affiliation":[{"name":"Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"},{"name":"First Faculty of Medicine, Charles University, Katerinsk\u00e1 32, 121 08 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Cermak","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-881X","authenticated-orcid":false,"given":"Monika","family":"Belickova","sequence":"additional","affiliation":[{"name":"Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminhematol.2005.01.002","article-title":"Management of anemia associated with myelodysplastic syndrome","volume":"42","year":"2005","journal-title":"Semin. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/17474086.2013.814456","article-title":"Iron chelation therapy in myelodysplastic syndromes: Where do we stand?","volume":"6","author":"Mitchell","year":"2013","journal-title":"Expert Rev. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-019-00592-5","article-title":"Iron chelation therapy for myelodysplastic syndrome: A systematic review and meta-analysis","volume":"20","author":"Liu","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000204488","article-title":"Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron-loading anaemia","volume":"89","author":"Vreugdenhil","year":"1993","journal-title":"Acta Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"64330","DOI":"10.18632\/oncotarget.11830","article-title":"The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2\/\u03b2-catenin signaling in human multiple myeloma","volume":"7","author":"Kamihara","year":"2016","journal-title":"Oncotarget"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18748","DOI":"10.18632\/oncotarget.4349","article-title":"Targeting cancer by binding iron: Dissecting cellular signalling pathways","volume":"6","author":"Lui","year":"2015","journal-title":"Oncotarget"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bjh.13151","article-title":"The oral iron chelator deferasirox inhibits NF-\u03baB mediated gene expression without impacting on proximal activation: Implications for myelodysplasia and aplastic anaemia","volume":"168","author":"Banerjee","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_8","first-page":"664","article-title":"Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients","volume":"20","author":"Lumbreras","year":"2020","journal-title":"Pharm. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1349-7006.2009.01131.x","article-title":"The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1","volume":"10","author":"Ohyashiki","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.critrevonc.2019.06.002","article-title":"Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions","volume":"141","author":"Leitch","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3324\/haematol.2009.016824","article-title":"Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging","volume":"95","author":"Messa","year":"2010","journal-title":"Haematologica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fonc.2018.00549","article-title":"Iron in the Tumor Microenvironment-Connecting the Dots","volume":"8","author":"Tymoszuk","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.celrep.2014.02.042","article-title":"Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function","volume":"7","author":"Shen","year":"2014","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/carcin\/bgg116","article-title":"The effect of potent iron chelators on the regulation of p53: Examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1","volume":"24","author":"Liang","year":"2003","journal-title":"Carcinogenesis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molcel.2013.10.031","article-title":"Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response","volume":"53","author":"Wu","year":"2014","journal-title":"Mol. Cell."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2009.07720.x","article-title":"Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes","volume":"146","author":"Pellagatti","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3324\/haematol.2012.063420","article-title":"Infections in myelodysplastic syndromes","volume":"97","author":"Toma","year":"2012","journal-title":"Haematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.leukres.2018.02.005","article-title":"Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy","volume":"67","author":"Wong","year":"2018","journal-title":"Leuk. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: From stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100617","DOI":"10.1016\/j.blre.2019.100617","article-title":"Too much iron: A masked foe for leukemias","volume":"39","author":"Brissot","year":"2020","journal-title":"Blood Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4049\/jimmunol.163.2.947","article-title":"Neutrophil defensins induce histamine secretion from mast cells: Mechanisms of action","volume":"163","author":"Befus","year":"1999","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI114394","article-title":"Monocyte-chemotactic activity of defensins from human neutrophils","volume":"84","author":"Territo","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.68.1.9","article-title":"Human neutrophil defensins selectively chemoattract na\u00efve T and immature dendritic cells","volume":"68","author":"Yang","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1074\/jbc.271.6.2935","article-title":"Identification of defensin-1, defensin-2 and CAP37\/azurocidin as T cell chemoattractant proteins released from interleukin-8-stimulated neutrophils","volume":"271","author":"Chertov","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.4049\/jimmunol.0804187","article-title":"Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins","volume":"183","author":"Miles","year":"2009","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.1601831113","article-title":"Neutrophil-derived alpha defensins control inflammation by inhibiting macrophage mRNA translation","volume":"113","author":"Brook","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/aps.2010.117","article-title":"Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders","volume":"31","author":"Wu","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.4049\/jimmunol.1301055","article-title":"CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis","volume":"192","author":"Parlato","year":"2014","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nchembio.1891","article-title":"Human calprotectin is an iron-sequestering host-defense protein","volume":"11","author":"Nakashige","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2141.2002.03803.x","article-title":"Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement","volume":"119","author":"Imamura","year":"2002","journal-title":"Br. J. Haemat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/blood-2002-11-3541","article-title":"Hmgb3: An HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation","volume":"102","author":"Nemeth","year":"2003","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/j.1460-2075.1993.tb05757.x","article-title":"Fusion between a novel Kr\u00fcppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia","volume":"12","author":"Chen","year":"1993","journal-title":"EMBO J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1128\/MCB.23.24.9375-9388.2003","article-title":"Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression","volume":"23","author":"McConnell","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"36266","DOI":"10.18632\/oncotarget.9200","article-title":"TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes","volume":"7","author":"Belickova","year":"2016","journal-title":"Oncotarget"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/1\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:07:57Z","timestamp":1760159277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/1\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ph14010041"],"URL":"https:\/\/doi.org\/10.3390\/ph14010041","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]}}}